Actimis Pharmaceuticals
Actimis Pharmaceuticals is a biopharmaceutical company developing small molecule therapeutics for respiratory and inflammatory disorders.
Launch date
Employees
Market cap
-
Enterprise valuation
€35—52m (Dealroom.co estimates Jun 2008.)
San Diego California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$6.0m | Series A | ||
$9.6m | Early VC | ||
* | N/A | Acquisition | |
| Total Funding | €14.2m | ||
Recent News about Actimis Pharmaceuticals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.